Skip to main content
. Author manuscript; available in PMC: 2020 May 22.
Published in final edited form as: Nat Microbiol. 2019 Jul 29;4(11):1919–1929. doi: 10.1038/s41564-019-0492-8

Figure 1. Geographical distribution of carbapenem resistance mechanisms amongst isolates submitted during the EuSCAPE survey.

Figure 1

a, Total number of isolates submitted by participating countries that were analysed in this study. Isolates are partitioned into those that possess one or more of four major carbapenemase genes (blaKPC-like, blaOXA-48-like, blaNDM-like and blaVIM-like) regardless of whether they were submitted as carbapenem-non-susceptible or -susceptible, those which lack any of the four genes that were submitted as carbapenem-non-susceptible (“Other mechanism”), and those submitted as carbapenem-susceptible. b, Pie charts representing the proportion of isolates submitted as carbapenem-non-susceptible from participating hospitals with different resistance mechanisms as in a.